Oncopeptides AB (publ) (STO:ONCO)
Sweden · Delayed Price · Currency is SEK 3.150
-0.100 (-3.08%)
Jan 21, 2026, 12:47 PM CET
Oncopeptides AB Market Cap
Oncopeptides AB has a market cap or net worth of 886.3 million as of January 21, 2026. Its market cap has increased by 164.70% in one year.
Market Cap
886.30M
Enterprise Value
887.15M
Revenue
62.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.15
Market Cap Chart
Since February 22, 2017, Oncopeptides AB's market cap has decreased from 1.67B to 886.30M, a decrease of -46.92%. That is a compound annual growth rate of -6.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 886.30M | -32.36% |
| Dec 30, 2025 | 1.31B | 291.35% |
| Dec 30, 2024 | 334.83M | -53.79% |
| Dec 29, 2023 | 724.64M | -36.76% |
| Dec 30, 2022 | 1.15B | 81.18% |
| Dec 30, 2021 | 632.45M | -94.51% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 114.29B |
| Getinge AB | 60.57B |
| BioArctic AB | 48.85B |
| Sectra AB | 44.35B |
| Camurus AB | 41.24B |
| Medicover AB | 31.93B |
| Asker Healthcare Group AB | 30.15B |
| Elekta AB | 24.17B |